In the last two decades, the ability to reprogram adult skin cells into induced pluripotent stem cells (iPSCs) has revolutionized medicine. We can now grow "mini-brains," beating heart cells, and functional liver tissue in a dish. However, a fundamental problem persists across the field: these lab-grown cells are biologically "young."
Whether they are neurons, heart cells, or liver cells, stem-cell-derived progeny typically reach a developmental plateau that corresponds to fetal or neonatal stages. This "maturity gap" creates a significant hurdle for studying diseases that take decades to manifest, such as Alzheimer’s or ALS.
The Fetal Plateau
When we reprogram a cell, we effectively reset its biological clock to zero. As these cells differentiate into specific types—like the motor neurons studied by Emily G. Baxi in the Answer ALS project—they follow a natural developmental timeline. However, in a standard laboratory incubator, that timeline often stalls.
Wei Zheng and colleagues have noted that current protocols for glial cells often produce phenotypes that reflect fetal states rather than the mature states found in adults Differentiation of Glial Cells From hiPSCs. Similarly, Zhixiong Sun found that even extended cultivation of brain organoids fails to produce neurons with the physiological and structural complexity of the adult human brain Genomic and Transcriptomic Signatures of SETD1A Disruption.
This isn't just a matter of waiting longer. The cells seem to lack the environmental triggers—hormonal shifts, mechanical stresses, and complex cell-to-cell interactions—that push a tissue from a growing "embryonic" state into a stable "adult" state.
Why Maturity Matters for Disease Modeling
The maturity gap is most problematic when modeling late-onset neurodegenerative diseases. As Jessica Di Re explains, iPSC-derived neurons represent an embryonic state that may fail to capture the decades-long progression of disorders like schizophrenia or Alzheimer's βIV spectrin abundancy, cellular distribution and sensitivity to AKT/GSK3 regulation in schizophrenia.
If a disease is caused by the cumulative buildup of cellular stress over 60 years, a "newborn" neuron in a dish might appear perfectly healthy. For example, Chris McDermott‐Roe observed that heart cells with a specific genetic mutation appeared normal under standard conditions, only collapsing when subjected to artificial proteotoxic stress Investigation of a dilated cardiomyopathy–associated variant in BAG3. Without the "wear and tear" of aging, the underlying vulnerability remains hidden.
The Missing Niche
A cell's identity is defined not just by its genes, but by its "niche"—the surrounding environment of other cells, blood vessels, and the extracellular matrix (ECM).
- Non-Neuronal Support: Velina Kozareva highlights that many models lack critical interactions with glia, which are essential for replicating the multicellular environment of the aging brain Integrative multiomic analysis links TDP-43-driven splicing defects to cascading proteomic disruption.
- Vascularization: Without blood vessels, organoids often suffer from internal "starvation" or lack the protective signals found in a developed brain. Xin-Yao Sun demonstrated that adding vasculature to organoids provides protective signals like BMP2, which are absent in simpler models Neural Responses to Hypoxic Injury in a Vascularized Cerebral Organoid Model.
- Structural Scaffolds: Alice E. Stanton found that standard 3D scaffolds often fail to replicate the biochemical cues of the human brain's ECM. Without this "Neuromatrix," neurons remain functionally immature and lack robust electrical activity Engineered 3D Immuno-Glial-Neurovascular Human miBrain Model.
Bridging the Gap
To solve this, researchers are exploring "artificial aging" techniques. Philipp Hornauer and others are developing methods to chemically or genetically accelerate the biological clock of iPSC-derived neurons to better reflect the state of an aging brain Downregulating α-synuclein in iPSC-derived dopaminergic neurons.
In other tissues, the challenge is similar. Dongyan Shi found that while stem-cell-derived liver cells (HLCs) adopt the correct genetic profile, they remain metabolically immature compared to primary adult hepatocytes Transcriptome Profiling Reveals Distinct Phenotype of Human Bone Marrow Mesenchymal Stem Cell-derived Hepatocyte-like cells.
The goal of the field is moving beyond mere specification (making the right cell type) toward maturation (making the cell act its age). Only by bridging this maturity gap can we ensure that the discoveries made in a dish will actually translate to the patients in the clinic.